Showing results (1491-1500 of 5,932) with videos related to
Sort By:
Pageof 594
The Prostate|January 7, 2016
The interaction between androgen receptor and PDGF-D in the radiation response of prostate carcinomaPeter Paximadis, Abdo J Najy, Michael Snyder, et al.The Prostate|December 31, 2015
The STEAP1(262-270) peptide encapsulated into PLGA microspheres elicits strong cytotoxic T cell immunity in HLA-A*0201 transgenic mice--A new approach to immunotherapy against prostate carcinomaValerie L Herrmann, Daniel E Wieland, Daniel F Legler, et al.The Prostate|March 24, 2016
Chemotherapy following radium-223 dichloride treatment in ALSYMPCAOliver Sartor, Peter Hoskin, Robert E Coleman, et al.The Prostate|February 12, 2016
Silodosin inhibits prostate cancer cell growth via ELK1 inactivation and enhances the cytotoxic activity of gemcitabineTakashi Kawahara, Ali Kadhim Aljarah, Hasanain Khaleel Shareef, et al.The Prostate|February 5, 2016
Regulating NKX3.1 stability and function: Post-translational modifications and structural determinantsAchuth Padmanabhan, Varsha Rao, Angelo M De Marzo, et al.The Prostate|March 19, 2016
The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisitedRuben G Cremers, Katja K Aben, Inge M van Oort, et al.The Prostate|March 19, 2016
MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrenceRobert K Nam, Tania Benatar, Christopher J D Wallis, et al.The Prostate|January 1, 1989
Immunohistochemical localization of laminin in the basement membranes of normal, hyperplastic, and neoplastic human prostateA A Sinha, D F Gleason, M J Wilson, et al.The Prostate|April 11, 2016
Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancerTibor Szarvas, Henning Reis, Frank Vom Dorp, et al.The Prostate|April 21, 2015
Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptorYan Wang, Gaolei Liu, Dali Tong, et al.Pageof 594